United States · 
Who invested in Etubics?
Etubics's investors include National Institute of Allergy and Infectious Diseases.
United States · Venture startup
Who invested in Etubics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Etubics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$4.4Mraised across 1 round since 2014, from 1 source
- Latest round
- Venture, $4.4MApr 2014
- Investors
- 1
The rounds
- Apr 2014
Founders and team
From Etubics's own website: 8 on the team.
- Rich AdcockPresident & Chief Executive Officer
- Elizabeth GabitzschSenior Vice President, Product Development & Vaccine Programs
- Emily ArisonSenior Vice President of Human Resources
- Matthew HilmanVice President US Commercial – Urologic Oncology
- Sarah SingletonChief Communications Officer & Head of Patient Advocacy
- David SachsChief Financial Officer
- Dr. Patrick Soon-ShiongExecutive Chairman and Global Chief
- Regan LauerChief Accounting Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Etubics
How much has Etubics raised?
Etubics has raised $4.4M across 1 round since 2014.
When did Etubics last raise?
Etubics's most recent round was a Venture of $4.4M in Apr 2014.
What was Etubics's biggest round?
Its most recent round, $4.4M in Apr 2014, is also its largest on record.
Who backed Etubics first?
Etubics's first round on record, in Apr 2014, was backed by National Institute of Allergy and Infectious Diseases.
What stage is Etubics at?
Etubics's latest named round is a Venture, in Apr 2014.
Where is Etubics based?
Etubics is based in the United States.
Companies like Etubics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.